Talaris Therapeutics Inc. (TALS) Fundamentals

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.
SHARE INFORMATION
Market Cap$ 59,663,297
Shares Outstanding41,722,585
Float24,181,440
Percent Float57.96%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.27
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions150
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months183,802
Institutional Holdings Percent77.4%
Institutional Sold Previous 3 Months1,382,817
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months924,814
Insider Holdings Percent10.1
Insider Sold Previous 3 Months911,932
Insider Shares Owned4,204,338
TRADING INFO
52 Week High$ 16.63
52 Week Low$ 1.16
52 Week High Change$ -88.30
21 Day Moving Average$ 1.5048
21 Day Extended Moving Average$ 1.582
50 Day Moving Average$ 2.0886
50 Day Extended Moving Average$ 2.1357
200 Day Moving Average$ 5.4469
200 Day Extended Moving Average$ 5.2439
10 Day Average Volume131,816
20 Day Average Volume167,272
30 Day Average Volume331,282
50 Day Average Volume240,760
Alpha-0.089162
Beta1.9393
Standard Deviation0.259410
R20.194588
7 Day Price Change$ -0.04
7 Day Percent Change-2.72%
21 Day Price Change$ -0.06
21 Day Percent Change-4.03%
30 Day Price Change$ 0.01
30 Day Percent Change0.7%
Month to Date Price Change$ -0.08
Month to Date Percent Change-5.3%
Quarter to Date Price Change$ -1.20
Quarter to Date Percent Change-45.63%
180 Day Price Change$ -5.53
180 Day Percent Change-79.45%
200 Day Price Change$ -5.67
200 Day Percent Change-79.86%
Year to Date Price Change$ -13.86
Year to Date Percent Change-90.65%

Talaris Therapeutics Inc. (TALS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.30
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio21.60
Leverage Ratio1.00
Quick Ratio21.10
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-0.80
Enterprise Value$ -133,105,141
Price to Sales0.00
Price to Free Cash-1.00
PE High Last 5 Years0.00
Price To Book0.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-29.75
Return on Equity-30.90
Return on Capital-30.48

Talaris Therapeutics Inc. (TALS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDeloitte & Touche LLP
CEOScott Requadt
Emplyoees131
Last AuditUQ
CIK0001827506
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address570 South Preston Street
Louisville, KY 40202
Websitehttps://www.talaristx.com
Facsimile-
Telephone+1 502 398-9250
Email-


Your Recent History
NASDAQ
TALS
Talaris Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.